- Oct 13, 2020

ICR to study fadraciclib to treat paediatric neuroblastoma

The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma.

Can Children Get Breast Cancer?

Potential Genetic Variants Linked to Increased Cancer Risk in Children with Birth Defects

Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivors

Data Support Whole Brain Irradiation Reduction in Pediatric Cancer Survivors

Diet High in Sugar May Accelerate Aging in Survivors of Childhood Cancer

World-first clinical trial in ‘man’s best friend’ could unlock breakthrough for kids with cancer

Altered cell behavior behind resistance in neuroblastoma

McMaster University researchers pinpoint potential treatment for lethal childhood cancer

Chronic Conditions More Likely Among Survivors of Pediatric Wilms Tumor

Changes to chromosomes impact how children’s brain tumours respond to treatment

Recent Posts

ICR to study fadraciclib to treat paediatric neuroblastoma

Archive

Search By Tags